Literature DB >> 1267550

Elevated plasma MB creatine phosphokinase activity. A specific marker for myocardial infarction in perioperative patients.

R Roberts, B E Sobel.   

Abstract

Plasma MB creatine phosphokinase (CPK) activity is consistently elevated following myocardial infarction (MI). To determine whether elevations of plasma MB CPK activity is a specific index of myocardial injury, CPK and isoenzymes were assayed by a quantitative kinetic fluorometric technique in fresh organs obtained at surgery. Analysis of CPK isoenzymes showed myocardium to be essentially the only organ with MB CPK. Operative procedures included thoracic, neck, genitourinary, and orthopedic surgery. Total plasma CPK activity increased in all patients; however, MB CPK activity was not elevated. Thus, (1) the heart appears to be the only organ that is capable of liberating substantial amounts of MB CPK into plasma; (2) in spite of notably increased CPK activity after cardiac surgery, MB CPK activity is not elevated; and (3) increased MB CPK activity is a reliable index of MI in postoperative patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1267550

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

Review 1.  Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction.

Authors:  P M Guzy
Journal:  West J Med       Date:  1977-12

2.  Enzymatic diagnosis of infarction.

Authors:  B E Sobel
Journal:  West J Med       Date:  1977-12

3.  Biochemical examination of sera during systemic Candida infection in mice.

Authors:  D Oblack; J Schwarz; I A Holder
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

4.  Myxedema mimicking myocardial ischemia in a young black male.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1991-05       Impact factor: 1.798

5.  Heart type creatine kinase isoenzyme (CK MB) in acute cerebral disorders.

Authors:  M Kaste; H Somer; A Konttinen
Journal:  Br Heart J       Date:  1978-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.